大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/12/18 | 8,610 | 8,674 | 8,597 | 8,609 | +2 | ±0% | 858,300 |
| 2024/12/17 | 8,710 | 8,736 | 8,570 | 8,607 | -133 | -1.5% | 1,064,400 |
| 2024/12/16 | 8,689 | 8,767 | 8,673 | 8,740 | +51 | +0.6% | 728,700 |
| 2024/12/13 | 8,710 | 8,846 | 8,608 | 8,689 | -158 | -1.8% | 1,518,000 |
| 2024/12/12 | 8,839 | 8,931 | 8,780 | 8,847 | +107 | +1.2% | 1,132,700 |
| 2024/12/11 | 8,888 | 8,938 | 8,707 | 8,740 | -58 | -0.7% | 1,136,800 |
| 2024/12/10 | 8,909 | 8,910 | 8,750 | 8,798 | +14 | +0.2% | 853,400 |
| 2024/12/09 | 8,885 | 8,938 | 8,747 | 8,784 | -24 | -0.3% | 1,014,600 |
| 2024/12/06 | 9,093 | 9,099 | 8,700 | 8,808 | -252 | -2.8% | 992,200 |
| 2024/12/05 | 8,962 | 9,074 | 8,930 | 9,060 | +118 | +1.3% | 927,000 |
| 2024/12/04 | 9,155 | 9,161 | 8,883 | 8,942 | -214 | -2.3% | 1,132,600 |
| 2024/12/03 | 8,948 | 9,211 | 8,915 | 9,156 | +307 | +3.5% | 1,496,700 |
| 2024/12/02 | 8,686 | 8,938 | 8,686 | 8,849 | +164 | +1.9% | 1,029,800 |
| 2024/11/29 | 8,663 | 8,789 | 8,618 | 8,685 | -3 | ±0% | 870,100 |
| 2024/11/28 | 8,600 | 8,700 | 8,588 | 8,688 | +25 | +0.3% | 845,000 |
| 2024/11/27 | 8,716 | 8,725 | 8,600 | 8,663 | +50 | +0.6% | 1,097,000 |
| 2024/11/26 | 8,724 | 8,759 | 8,513 | 8,613 | -186 | -2.1% | 1,243,800 |
| 2024/11/25 | 9,000 | 9,060 | 8,799 | 8,799 | -111 | -1.2% | 3,199,500 |
| 2024/11/22 | 8,938 | 8,996 | 8,840 | 8,910 | -42 | -0.5% | 1,053,200 |
| 2024/11/21 | 9,071 | 9,180 | 8,952 | 8,952 | -48 | -0.5% | 989,200 |
| 2024/11/20 | 8,755 | 9,044 | 8,725 | 9,000 | +238 | +2.7% | 1,342,200 |
| 2024/11/19 | 8,758 | 8,829 | 8,696 | 8,762 | +4 | ±0% | 1,488,100 |
| 2024/11/18 | 8,980 | 9,039 | 8,723 | 8,758 | -370 | -4.1% | 1,605,400 |
| 2024/11/15 | 9,271 | 9,340 | 9,117 | 9,128 | -66 | -0.7% | 903,400 |
| 2024/11/14 | 9,083 | 9,277 | 9,080 | 9,194 | +84 | +0.9% | 971,700 |
| 2024/11/13 | 9,276 | 9,331 | 9,028 | 9,110 | -231 | -2.5% | 1,547,400 |
| 2024/11/12 | 9,500 | 9,558 | 9,317 | 9,341 | -104 | -1.1% | 986,300 |
| 2024/11/11 | 9,580 | 9,605 | 9,430 | 9,445 | -53 | -0.6% | 994,000 |
| 2024/11/08 | 9,516 | 9,612 | 9,444 | 9,498 | -2 | ±0% | 1,338,900 |
| 2024/11/07 | 9,657 | 9,669 | 9,401 | 9,500 | -111 | -1.2% | 1,416,200 |
| 2024/11/06 | 9,402 | 9,647 | 9,338 | 9,611 | +199 | +2.1% | 1,233,300 |
| 2024/11/05 | 9,454 | 9,454 | 9,234 | 9,412 | +205 | +2.2% | 1,545,000 |
| 2024/11/01 | 9,090 | 9,294 | 9,084 | 9,207 | -65 | -0.7% | 1,622,500 |
| 2024/10/31 | 9,171 | 9,338 | 8,900 | 9,272 | +113 | +1.2% | 2,338,000 |
| 2024/10/30 | 9,160 | 9,277 | 9,145 | 9,159 | -24 | -0.3% | 2,673,800 |
| 2024/10/29 | 9,051 | 9,222 | 9,007 | 9,183 | +33 | +0.4% | 1,035,000 |
| 2024/10/28 | 9,063 | 9,178 | 9,022 | 9,150 | +114 | +1.3% | 867,600 |
| 2024/10/25 | 9,170 | 9,180 | 8,982 | 9,036 | -159 | -1.7% | 826,500 |
| 2024/10/24 | 9,034 | 9,244 | 9,004 | 9,195 | +91 | +1% | 1,446,500 |
| 2024/10/23 | 9,087 | 9,267 | 9,070 | 9,104 | +97 | +1.1% | 1,886,100 |
| 2024/10/22 | 9,042 | 9,081 | 8,941 | 9,007 | -50 | -0.6% | 1,069,200 |
| 2024/10/21 | 8,978 | 9,125 | 8,905 | 9,057 | +8 | +0.1% | 855,100 |
| 2024/10/18 | 8,860 | 9,126 | 8,854 | 9,049 | +295 | +3.4% | 1,285,300 |
| 2024/10/17 | 8,719 | 8,783 | 8,617 | 8,754 | +51 | +0.6% | 1,208,900 |
| 2024/10/16 | 8,766 | 8,869 | 8,693 | 8,703 | -63 | -0.7% | 1,140,300 |
| 2024/10/15 | 8,880 | 8,948 | 8,766 | 8,766 | -51 | -0.6% | 1,265,200 |
| 2024/10/11 | 8,829 | 8,860 | 8,752 | 8,817 | -11 | -0.1% | 1,192,700 |
| 2024/10/10 | 8,733 | 8,873 | 8,689 | 8,828 | +118 | +1.4% | 1,032,900 |
| 2024/10/09 | 8,650 | 8,756 | 8,580 | 8,710 | +161 | +1.9% | 1,293,600 |
| 2024/10/08 | 8,349 | 8,549 | 8,309 | 8,549 | +50 | +0.6% | 754,000 |
151～
200
件表示中 / 3580件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 745,800円 | +2.2% | +28.0% | 1.88% | 11.94倍 | 1.45倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 367,800円 | +6.0% | +4.0% | 2.12% | 22.84倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 421,700円 | -1.1% | +75.3% | 4.74% | 29.21倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 157,600円 | +0.9% | +380.2% | 4.95% | 21.71倍 | 1.87倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,700円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.59倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
